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Abstract
Conventional self-assembling peptide hydrogels are effective as topical hemostatic agents. However, there is a possibility to
harm living tissues due to their low pH. The aim of the present study was to demonstrate the efficacy of SPG-178, a neutral
self-assembling peptide hydrogel, as a topical hemostatic agent. First, we measured the bleeding duration of incisions made
on rat livers after application of SPG-178 (1.0% w/v), SPG-178 (1.5% w/v), RADA16 (1.0% w/v), and saline (n = 12/group).
Second, we observed the bleeding surfaces by transmission electron microscopy immediately after hemostasis. Third, we
measured the elastic and viscous responses (G9 and G0, respectively) of the hydrogels using a rheometer. Our results
showed that bleeding duration was significantly shorter in the SPG-178 group than in the RADA16 group and that there
were no significant differences in transmission electron microscopy findings between the groups. The greater the G9 value
of a hydrogel, the shorter was the bleeding duration. We concluded that SPG-178 is more effective and has several
advantages: it is non-biological, transparent, nonadherent, and neutral and can be sterilized by autoclaving.
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Introduction
Hemostasis is one of the most important aspects in surgery
because intraoperative blood loss increases the incidence of
postoperative morbidity and mortality [1,2]. Currently, various
biological and synthetic topical agents shown to facilitate
intraoperative hemostasis are commercially available. Biological
hemostatic agents include gelatin products, oxidized cellulose,
microfibrillar collagen, topical thrombin, fibrin sealants, and
platelet gels, whereas cyanoacrylate is a commonly applied
synthetic hemostatic agent. Thus, many topical hemostatic agents
are available. However, there are several problems [3,4]. For
example, most of sheet- and powder-type topical hemostatic agents
are opaque. Therefore, it is almost impossible to confirm the
completion of hemostasis by observing the bleeding surface
through these agents. The use of biological topical hemostatic
agents, which are often administered during surgery, could cause
risks of inducing allergic reactions and unknown infectious diseases
[5,6].
To solve these problems, the use of self-assembling peptide
hydrogels has been proposed [7]. The complete sequence of a self-
assembling peptide was originally found in a region of alternating
hydrophobic and hydrophilic residues in a yeast protein, zuotin
[8], which was characterized by a stable b-sheet structure and
known to undergo self-assembly into nanofibers that could further
form a hydrogel [9,10]. Self-assembling peptide hydrogels have
already been employed for topical hemostasis [7,11–13], tissue
engineering [14–17], drug delivery systems [18,19], and wound
healing [20,21].
RADA16 (RADARADARADARADA; R= arginine, A=
alanine, and D= aspartic acid, BD Biosciences, San Jose, CA,
USA) is a representative self-assembling peptide hydrogel, the use
of which as a topical hemostatic agent has already been reported
[7,13]. However, because of its very low pH (approximately 3–4),
untreated RADA16 retains the potential to harm living tissues.
Therefore, to avoid cell necrosis and receive the full benefit of the
self-assembling peptide technology, the pre-neutralization proce-
dure was often employed [22–29]. In one particular case, it took a
week to gradually neutralize the hydrogel by a solvent substitution
though the neutralized RADA16 successfully demonstrate its
capability to bridge the injured spinal cord of rats [29]. In
addition, the hydrogel structure of RADA16 is unstable under
physiological condition. After the neutralization procedure, the
hydrogel tends to break under mechanical stress [22,30]. The
RADA16 peptide molecule has the same number of positive and
negative charges. The isoelectric point is 6.1 [31], so that its net
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charge is nearly zero at physiological pH conditions (approxi-
mately pH 7). The peptide’s solubility is accordingly very low.
Therefore, it can easily precipitate or break. In general, other
conventional self-assembling peptide hydrogels have similar
problems.
For those reasons, we considered using the neutral (pH=6.5–
7.5) self-assembling peptide hydrogel SPG-178 (Self-assembling
Peptide Gel, amino acid sequence #178; [CH3CONH] -
RLDLRLALRLDLR-[CONH2]; R= arginine, L= leucine,
D= aspartic acid, and A= alanine, Menicon Co., Ltd., Nagoya,
Japan), as a hemostatic agent. The SPG-178 peptide is synthesized
through a chemical process. The peptide has been shown to form
an antiparallel b-sheet structure as its secondary structure in
aqueous solution. The peptide self-assembles to form nanofibers of
,10-nm diameter that can further form a stable net structure. The
results of three-dimensional cell culture have shown that SPG-178
is noncytotoxic. The isoelectric point of SPG-178 was designed to
be 11.5 by employing four cationic arginine and two aspartic acid
residues for better stability in neutral pH environment (around
pH=7) [32]. The aim of the present study was to investigate the
efficacy of SPG-178 as a topical hemostatic agent in a rat liver
laceration model. We also compared the SPG-178 and RADA16
hydrogels using transmission electron microscopy (TEM) and
rheology measurements.
Materials and Methods
The SPG-178 (1.0% and 1.5% w/v) and RADA16 (1.0% w/v)
hydrogels were purchased from Menicon Co., Ltd. and BD
Biosciences (San Jose, CA, USA), respectively.
Ethics Statement
All experimental rats were housed in a climate-controlled
facility and food (commercial pellets for experimental animals) and
water was available ad libitum. All animal experiments were
performed in strict accordance with the guidelines of the National
Institutes of Health (Bethesda, MD, USA) and were performed at
the Department of Animal Resources, Advanced Science Re-
search Center, Okayama University (Okayama, Japan) after
receipt of approval from the Animal Care and Use Committee,
Okayama University (permit number OKU-2012239).
Bleeding Duration in a Rat Liver Laceration Model
A total of 48 male Wistar rats (8 weeks of age) were randomly
divided into four groups of 12 rats each: (1) SPG-178 (1.0% w/v),
(2) SPG-178 (1.5% w/v), (3) RADA16 (1.0% w/v), and (4) a saline
group (control). All rats were anesthetized by intraperitoneal
injection of pentobarbital sodium at a dose of 50 mg/kg and each
was placed in the supine position to open the abdomen to expose
the liver. Horizontal 10-mm incisions, 3 mm deep, were made
with a scalpel on the front of the lower part of the left lobe of the
liver, 100 mL of hydrogel or saline was applied to the bleeding
surface using a syringe fitted with a 27-G needle, and bleeding
duration was measured. The area was wiped and then washed
with saline 10 min later (Fig. 1) and the abdominal incision was
closed with sutures.
On postoperative day 7, the rats were anesthetized by
intraperitoneal injection of pentobarbital sodium at a dose of
50 mg/kg and the abdomen of each was opened to expose the
liver. Hepatectomy was then performed for histopathological
examination. The livers were fixed in 10% (w/v) formalin neutral
buffer solution for 5 days, dehydrated with graded concentrations
of ethanol, which was replaced with xylene, embedded in paraffin,
cut into 4.5-mm sections with a microtome, and plated on slides,
which were stained with hematoxylin and eosin and Masson’s
trichrome stain. The residual hydrogels and foreign body reaction
were examined under a light microscope. After hepatectomy, all
rats were sacrificed by intraperitoneal injection of pentobarbital
sodium at a dose of 120 mg/kg.
Statistical analysis was performed using Statistical Package for
Social Sciences software (SPSS Inc., Chicago, IL, USA). Inter-
group differences were identified by one-way analysis of variance
using the post-hoc Tukey’s honestly significant difference test to
allow for multiple comparisons. A probability (p) value of ,0.01
was considered statistically significant. All data are presented as
the mean 6 standard error of the mean.
TEM of Bleeding Liver Surfaces
As described above, all rats were anesthetized and hydrogels
(SPG-178, 1.5% w/v; RADA16, 1.0% w/v, respectively; n = 2
each) were applied to the lacerated livers. Hepatectomy was
performed 10 min later. However, the hydrogels were not wiped
clear to allow observation. After hepatectomy, all rats were
sacrificed by intraperitoneal injection of pentobarbital sodium at a
dose of 120 mg/kg. The livers were excised, fixed at 4uC overnight
in 0.1 M phosphate buffer containing 2% (v/v) glutaraldehyde
and 2% (v/v) paraformaldehyde, postfixed in 2% (w/v) osmium
tetroxide solution for 1.5 h at room temperature, dehydrated using
graded concentrations of ethanol, embedded in Spurr resin
(Polysciences, Inc., Warrington, PA, USA), cut into ultrathin
(60–90 nm) sections using a Leica EM UC6 ultramicrotome
(Leica, Vienna, Austria), and plated on slides, which were stained
with uranyl acetate and lead citrate, and then visualized using a
Hitachi 7650 electron microscope (Hitachi, Tokyo, Japan; Central
Research Laboratory, Okayama University Medical School)
operated at 80 kV. The sections were then stained with toluidine
blue stain to determine the area of interest.
Rheology Measurement of Hydrogels
Rheology measurements were performed for the hydrogels
(SPG-178, 1.0% w/v; SPG-178, 1.5% w/v; and RADA16, 1.0%
w/v). In brief, a 40-mL aliquot of the hydrogels was placed on the
plate of a rheometer (AR1000, TA Instruments, New Castle, DE,
USA) and a 20-mm-diameter, 1u aluminum cone with truncation
at 24 mm was then lowered so that the tip was 24 mm above the
plate. A solvent trap was used to maintain a water-saturated
atmosphere to prevent evaporation of the solvent during the
measurements. The hydrogels were tested over a range of
frequencies of 10–0.1 rad/s at 1.0-mNm oscillatory torque to
measure the storage modulus (G9, the elastic response) and the loss
modulus (G0, the viscous response) at 37uC.
Results
Bleeding Duration in the Rat Liver Laceration Model
The bleeding from liver incisions decreased immediately
following application of either hydrogel to the bleeding surface.
The bleeding surface was also visible with the application of both
hydrogels (Fig. 1, Video S1). The bleeding durations were
2.760.8, 7.961.6, 18.867.0, and 267.1663.4 s for the SPG-
178 (1.5% w/v), SPG-178 (1.0% w/v), RADA16 (1.0% w/v), and
saline groups, respectively (Fig. 2). The bleeding duration was
significantly shorter in the SPG-178 groups (1.0% w/v and 1.5%
w/v) than in the RADA16 (1.0% w/v) group (p=0.009).
Rebleeding attributable to removal of the hydrogels was not
observed in any rat. No rats died prior to being euthanized.
On postoperative day 7, the liver lacerations in all rats were
healed (Fig. 3) and no significant differences on gross liver
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Figure 1. Hemostasis in a rat liver laceration model. (A) Ventral, inferior, horizontal incisions were made with a scalpel on the left hepatic lobe.
(B) Bleeding decreased immediately following application of the 1.5% (w/v) SPG-178 hydrogel to the bleeding surface. Because SPG-178 is
transparent, the bleeding surface was visible. (C) SPG-178 was wiped and washed away with saline 10 min later, but rebleeding did not occur.
doi:10.1371/journal.pone.0102778.g001
Figure 2. Bleeding durations in a rat liver laceration model. Bleeding durations were 2.760.8, 7.961.6, and 18.867.0 in the 1.5% (w/v) SPG-
178, 1.0% (w/v) SPG-178, and 1.0% (w/v) RADA16 groups, respectively. Bleeding duration was significantly shorter in the SPG-178 (1.0% and 1.5% w/v)
groups than in the 1.0% (w/v) RADA16 group (**p,0.01; n = 12; one-way analysis of variance with post-hoc Tukey’s honestly significant difference
test). Bars represent means 6 standard errors of the mean.
doi:10.1371/journal.pone.0102778.g002
SPG-178 as a Topical Hemostatic Agent
PLOS ONE | www.plosone.org 3 July 2014 | Volume 9 | Issue 7 | e102778
inspection were detected between the four groups. Liver lacera-
tions were replaced with scar tissue in all cases. Remnants of the
hydrogels were identified in the scar tissue by histopathological
examination, but were invisible to the naked eye. Macrophage
infiltration and some foreign-body giant cells surrounding
hydrogel remnants were observed, but there was no evidence of
a strong foreign-body immune response. No differences were
observed between the SPG-178 and RADA16 groups on
histopathological examination of the liver tissues.
TEM of Bleeding Liver Surfaces
The boundary between the bleeding surface and the SPG-178
hydrogels was clearly observable by TEM; however, the hydrogels
were not always in direct contact with the liver surface. There was
evidence of trapped blood between SPG-178 and the hepatic
tissue (Fig. 4). Nanofibers of the SPG-178 hydrogels assembled
network structures, as expected, and the nanofiber assembly was
extremely dense near the interface with the liver surface, although
platelet aggregation was not observed. In the RADA16 group, the
TEM images were similar to those in a previous study [7]. No
differences were observed between the SPG-178 and RADA16
groups.
Rheology Measurement of Hydrogels
Frequency sweep measurements of the SPG-178 and RADA16
hydrogels showed that the G9 and G0 values were relatively
constant and that the G9 values were much greater than zero. The
G9 exceeded the G0 values over the entire frequency range (Fig. 5).
These results reflected the gel-like properties of the SPG-178 and
RADA16 hydrogels, with the bleeding duration decreasing as the
G9 value increased.
Discussion
To the best of our knowledge, the present study is the first to
report the hemostatic effects of SPG-178 as a highly effective
topical hemostatic agent (Fig. 2). SPG-178 has three advantages
compared with the conventional topical hemostatic agents: first, it
is transparent, thereby allowing the surgeon to visualize the
bleeding surface during the hemostasis procedure; second, it is a
synthetic material capable of minimizing the risk of unknown
Figure 3. Rat liver lacerations on postoperative day 7. (A) Healed liver lacerations in the 1.5% (w/v) SPG-178 group. (B) A liver laceration
replaced with scar tissue. Pieces of SPG-178 (arrowheads) are identifiable in the scar tissue, but were invisible to the naked eye. Macrophages and
some foreign body giant cells surrounding SPG-178 were observed, but there was no strong immune reaction against a foreign body. (C, D) A
representative figure of a healed liver laceration in the saline group. No significant differences were observed between the 1.5% (w/v) group and the
saline group. All slides were stained with Masson’s trichrome. Magnification,6100 (B, D).
doi:10.1371/journal.pone.0102778.g003
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infectious diseases associated with biological agents, that may
become more important in the future [5,6,13]; third, it does not
adhere stubbornly to bleeding surface. It is easy to remove if
required.
Compared with RADA16, SPG-178 hydrogels showed the
shorter bleeding durations. Because of its neutral pH, SPG-178
can be sterilized by autoclaving, which makes the sterilization
process simple. The RADA16 hydrogel, in contrast, decomposes
with autoclaving [32]. We confirmed that when SPG-178 was
prepared under acidic conditions, it also decomposed upon
autoclaving. In general, protein bioactivity is often lost with
disruption of the tertiary structure. However, a short peptide, such
as SPG-178, has no such tertiary structure. For this reason, as long
as the covalent bonds of SPG-178, which can be broken by
autoclaving in acidic condition, are maintained, it can self-
assemble to form a hydrogel. Because there are many cases and
conditions where the topical hemostatic agents are required, it is
important that the hemostatic procedure is as simple as possible.
SPG-178 can be directly applied to the bleeding surface without
considering the influence of acidic pH. Thus, SPG-178 hydrogel
has a potential to be a ready-to-use topical hemostatic agent when
it filled in a proper container. Importantly, in this study, there was
no difference in cytotoxicity because of the difference in pH
between the SPG-178 and RADA16 hydrogels (Fig. 3). Macro-
phage infiltration and some foreign body giant cells surrounding
both SPG-178 and RADA16 remnants were observed, and these
images were similar to those in a previous study [11]. A possible
cause for this observation is that the contact time between the liver
and hydrogel was short and the remnants were very few. We
speculate that differences would have become apparent if the
hydrogel had not been quickly removed. Accordingly, we are
Figure 4. Transmission electron microscopy of the bleeding liver surface. (A, B) Toluidine blue staining was performed to determine the
area of interest. SPG-178 was not always in direct contact with the liver. Blood was observed between SPG-178 and the hepatic tissue in most images.
Magnifications, 1006 (A) and 4006 (B). (C, D) Assembled nanofibers of SPG-178 forming a network structure. The density of the nanofibers is
extremely densely near the boundary. Scale bars, 2 mm (C) and 1 mm (D).
doi:10.1371/journal.pone.0102778.g004
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currently investigating the long-term pharmacokinetics of the
SPG-178 hydrogel.
The hemostatic mechanism of these hydrogels has already been
reported [7,11,12,13]. In brief, the peptide first comes in contact
with electrolytes in body fluids that promote nanofiber assembly
and network structure formation, described previously as ‘‘multi-
ple-layered fishing nets.’’ The nets then cover the bleeding surface
and prevent the escape of cells and fluid. In this study, application
of SPG-178 resulted in an extremely dense assembly of nanofibers
on the bleeding surface (Fig. 4). It is already known that the
hemostasis is not explainable by clotting or platelet aggregation.
Blood clots are produced after injury, but do not begin to form
until after 1–2 min [7]. Besides, transmission electron microscopy
images showed no evidence of platelet aggregation in this study or
in previous reports [7,11]. Another study reported the antithrom-
botic effect of L-arginine, that may explain a role of L-arginine
residues in SPG-178 and other self-assembling peptide in this
effect [33]. We accordingly propose that the hemostatic mecha-
nism of SPG-178 is the same as that of other self-assembling
peptide hydrogels. In this study, it was also interesting to note that
hemostasis proceeded with time, given that there was no instance
of rebleeding when the hydrogels were removed 10 min after
Figure 5. Rheology measurement of the hydrogels. The storage modulus (G9, the elastic response) and the loss modulus (G0, the viscous
response) values were relatively constant, and the G9 values were much greater than zero. In addition, the G9 values over the entire frequency range
exceeded those of G0. These results reflect the gel-like property of the SPG-178 and RADA16 hydrogels.
doi:10.1371/journal.pone.0102778.g005
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application but that rebleeding occurred when the hydrogels were
removed immediately after application. We accordingly propose
that hemostasis occurred naturally by physiological mechanisms
(vessel constriction, platelet formation, and coagulation) during the
10-min interval.
It is important to note the physiological parameters influencing
the postoperative hemostatic effect of hydrogels. First, the hydrogel
concentration will influence the hemostatic effect, with increased
effectiveness as a topical hemostatic agent as the concentration
increases [11,12]. Higher concentrations of the hydrogel allow
more rapid formation of a sufficient ‘‘fishing net’’ at bleeding sites.
In our study, the mean bleeding duration was shorter in the SPG-
178 (1.5% w/v) group than in the SPG-178 (1.0% w/v) group, but
the difference was not statistically significant (Fig. 2). However,
excessively high concentrations of these hydrogels are not desirable
because they are too firm and difficult to handle for such
applications. Besides, the product is expensive and technically
difficult to synthesize at high concentrations. We accordingly
propose that an optimal SPG-178 concentration for use as a
topical hemostatic agent is 1.5% w/v. Second, the hydrogel
viscoelasticity will also influence the hemostatic effect, with
increased effectiveness as a topical hemostatic agent as the
hydrogel G9 value increases [12]. The results of our study
demonstrated this principle (Fig. 5). The mean G9 value was
higher for SPG-178 than for RADA16 at the same concentrations.
SPG-178 was much firmer than RADA16. We speculate that a
higher viscoelasticity of these hydrogels can stop bleeding more
efficiently because they can remain in closer proximity to the
bleeding surface. The results thus suggest that the concentration
and viscoelasticity of hydrogels are important parameters influ-
encing their hemostatic effects. However, other parameters,
including reaction velocity between self-assembling peptides and
salt concentrations that may be present in body fluids, may play
important roles in these processes.
Our study showed that SPG-178 is a promising topical
hemostatic agent. We used a liver laceration model in this study
because it is easily reproducible. In previous studies, conventional
self-assembling peptide hydrogels showed hemostatic effects in the
superior sagittal sinus, spinal cord, artery, and skin [7,13]. Thus,
SPG-178 hydrogel can also be applicable in many surgical
procedures.
Conclusions
We have demonstrated the efficacy of SPG-178, a neutral self-
assembling peptide hydrogel as a topical hemostatic agent. The
bleeding duration was significantly shorter in the SPG-178 groups
than in the RADA16 group. SPG-178 was more effective than
RADA16, perhaps owing to the difference in viscoelasticity
between the SPG-178 and RADA16 hydrogels. SPG-178 is highly
effective and has many advantages: it is non-biological, transpar-
ent, nonadherent, neutral, and can be sterilized by autoclaving.
Supporting Information
Video S1 Hemostasis in a rat liver laceration model.
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